Incidence of New-Onset HTN Higher for COVID-19 Versus Influenza Patients
Medically reviewed by Drugs.com.
By Elana Gotkine HealthDay Reporter
MONDAY, Aug. 21, 2023 -- For patients with COVID-19, the incidence of new-onset persistent hypertension is higher than among those with influenza, according to a study published online Aug. 21 in Hypertension.
Vincent Zhang, from the Albert Einstein College of Medicine in Bronx, New York, and colleagues conducted a retrospective observational study in a major academic health system in New York City involving 45,398 patients with COVID-19 (March 2020 to August 2022) and 13,864 with influenza (January 2018 to August 2022) without hypertension history.
The researchers found that new-onset persistent hypertension occurred in 20.6 and 10.85 percent of hospitalized and nonhospitalized patients with COVID-19, respectively. There was no variation in the incidence of persistent hypertension among hospitalized patients across the pandemic, while among nonhospitalized patients, the incidence decreased from 20 percent in March 2020 to about 10 percent in October 2020, and then plateaued. Compared with individuals with influenza, hospitalized and nonhospitalized patients with COVID-19 were 2.23 and 1.52 times more likely, respectively, to develop persistent hypertension. Persistent hypertension occurred more often in older adults, men, patients with preexisting comorbidities, and those treated with pressor or corticosteroid medications. Persistent hypertension was predicted with 79 to 86 percent accuracy in mathematical models. Overall, 21.0 percent of hospitalized patients with COVID-19 without prior hypertension developed hypertension during hospitalization.
"Given the sheer number of people affected by COVID-19 compared to influenza, these statistics are alarming and suggest that many more patients will likely develop high blood pressure in the future, which may present a major public health burden," senior author Tim Q. Duong, Ph.D., also of the Albert Einstein College of Medicine, said in a statement.
Abstract/Full Text (subscription or payment may be required)
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted August 2023
Further Support and Information on COVID-19
Read this next
Residual Risk Seen for Death, Postacute Sequelae in Third Year After COVID-19 Hospitalization
THURSDAY, June 13, 2024 -- For individuals with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, the risks for death and postacute sequelae of COVID-19...
AI-Based Health Coaching Aids Blood Pressure Management
WEDNESDAY, June 12, 2024 -- Artificial intelligence (AI)-based, lifestyle coaching can improve blood pressure (BP) management, according to a study published online May 28...
Nurse Case Management Boosts Benefit of Home BP Telemonitoring
TUESDAY, June 11, 2024 -- Among predominantly low-income Black and Hispanic stroke survivors with uncontrolled hypertension, the addition of nurse case management (NCM) to home...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.